Foresight Diagnostics (a Natera company)

Precision medicine company dedicated to improving the lives of cancer patients through improved cancer detection methods

Founded 2020

Boulder, United States 112 employees Acquired Total: $379.25M Biotechnology, Health Care +1

General Information

Company Name Foresight Diagnostics (a Natera company)

Founded Year 2020

Location

Boulder, United States

Employees 112

Industries Biotechnology, Health Care, Pharmaceutical

Funding Stage Acquired

Business Model B2B, D2C, B2D

Revenue Model Service Fee, Usage Based, Product Sales

Social

BounceWatch is an independent company data service, not affiliated with Foresight Diagnostics (a Natera company). To contact Foresight Diagnostics (a Natera company), visit foresight-dx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Foresight Diagnostics (a Natera company) compare?

A PDF of Foresight Diagnostics (a Natera company) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Foresight Diagnostics (a Natera company) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Foresight Diagnostics (a Natera company) on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United States Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United States

Foresight Diagnostics (a Natera company) Alternatives

All Signals Trend Reports

About Foresight Diagnostics (a Natera company)

Foresight Diagnostics, now a part of Natera, is a precision medicine company committed to enhancing cancer patient care through advanced detection methodologies. Founded in 2020 by four Stanford University visionaries—physicians and scientists—the company is noted for its high-performing circulating tumor DNA (ctDNA) assays. By pioneering the phased variant detection method, its flagship product, Foresight CLARITY™, significantly increases the accuracy of ctDNA tests and minimal residual disease measurements.

Acquired by Natera for $275 million in December 2025, Foresight Diagnostics operates a state-of-the-art CLIA laboratory in Boulder, Colorado. The company's focus spans Biotechnology, Health Care, and Pharmaceutical sectors, aiming to redefine cancer diagnostics. This strategic acquisition underscores Natera's commitment to advancing precision oncology solutions in the United States.

Business keywords: Precision Medicine, Cancer Detection, Circulating Tumor DNA, Minimal Residual Disease, Liquid Biopsy, Phased Variant Detection, Bioinformatics, CLIA Laboratory, Oncology, Patient Management, Proprietary Technology, Assay Development, Stanford-founded, Pharmaceutical Partnerships, Cancer Diagnostics

Services & Products

diagnostic test development for cancer

ultra-sensitive MRD platform

clinical program execution

bioinformatics support

Target Customers

biopharmaceutical companies academic researchers oncologists

Funding Rounds & Investors (6)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Acquisition	$275.00M	1	Natera	01 Dec 2025
Series B	$33.00M	7	Pear Ventures, Civilization Ventures +5	01 Jul 2024
Series B	$58.75M	7	Pear Ventures, Civilization Ventures +5	01 Apr 2023
Series A	$12.50M	3	Pear Ventures, Civilization Ventures +1	01 Jun 2021
Round	Undisclosed	-		01 Dec 2020
Spinout	Undisclosed	1	Stanford University	01 Jan 2020

Foresight Diagnostics (a Natera company) Alternatives & Competitors

View All Alternatives

Foresight Diagnostics (a Natera company) vs

Predicine United States

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees

Biotechnology, Health Care

Compare Foresight Diagnostics (a Natera company) vs Predicine

Foresight Diagnostics (a Natera company) vs

CellMax Life United States

Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precance...

25 employees

Biotechnology, Health Care

Compare Foresight Diagnostics (a Natera company) vs CellMax Life

Foresight Diagnostics (a Natera company) vs

Adaptive Biotechnologies Corp. United States

Every immune system has a story to tell; the key is knowing how to listen.

IPO

654 employees

Biotechnology, Health Care

View all alternatives

FAQ About Foresight Diagnostics (a Natera company)

Precision medicine company dedicated to improving the lives of cancer patients through improved cancer detection methods

Foresight Diagnostics (a Natera company) was founded in 2020.

Foresight Diagnostics (a Natera company) is headquartered in Boulder, United States.

Foresight Diagnostics (a Natera company) operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Precision Medicine, Cancer Detection, Circulating Tumor DNA and Minimal Residual Disease. Its customers include biopharmaceutical companies, academic researchers and oncologists.

Foresight Diagnostics (a Natera company) has a B2B, D2C and B2D business model. Its revenue comes from Service Fee, Usage Based and Product Sales.

Foresight Diagnostics (a Natera company) has approximately 112 employees.

Foresight Diagnostics (a Natera company) has completed 6 funding rounds, raising a total of $379.25M. The latest funding stage is Acquired.

Foresight Diagnostics (a Natera company) offers: diagnostic test development for cancer, ultra-sensitive MRD platform, clinical program execution, bioinformatics support.

Top alternatives and competitors to Foresight Diagnostics (a Natera company) include Predicine, CellMax Life, Adaptive Biotechnologies Corp., Personal Genome Diagnostics, Singlera Genomics Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Foresight Diagnostics (a Natera company) and Predicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Foresight Diagnostics (a Natera company), https://bouncewatch.com/company/foresight-diagnostics-inc, updated 4 June 2026. When citing, please name BounceWatch and link this page.